MX9305933A - Metodo para antagonizar al 1,4,5-trifosfato de inositol. - Google Patents
Metodo para antagonizar al 1,4,5-trifosfato de inositol.Info
- Publication number
- MX9305933A MX9305933A MX9305933A MX9305933A MX9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A MX 9305933 A MX9305933 A MX 9305933A
- Authority
- MX
- Mexico
- Prior art keywords
- inositol
- triphosphate
- antagonize
- oligometers
- formula
- Prior art date
Links
- MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 title abstract 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 230000001766 physiological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/795—Polymers containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polyurethanes Or Polyureas (AREA)
Abstract
La invención proporciona oligómetros de la fórmula (ver fórmula I) que han demostrado ser antagonistas efectivos del 1,4,5-trifosfato de inositol (IP3) compitiendo con IP3 por los sitios de enlace. Al inhibir competitivamente la actividad del IP3, los oligómetros de esta invención puede modular la liberación de calcio intracelular y producir los efectos fisiológicos resultantes.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95239392A | 1992-09-28 | 1992-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9305933A true MX9305933A (es) | 1994-04-29 |
Family
ID=25492868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9305933A MX9305933A (es) | 1992-09-28 | 1993-09-27 | Metodo para antagonizar al 1,4,5-trifosfato de inositol. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0661982A1 (es) |
| JP (1) | JPH08502068A (es) |
| KR (1) | KR950703347A (es) |
| AU (1) | AU670962B2 (es) |
| CA (1) | CA2145681A1 (es) |
| HU (1) | HUT70192A (es) |
| IL (1) | IL107066A (es) |
| MX (1) | MX9305933A (es) |
| NO (1) | NO951163D0 (es) |
| NZ (1) | NZ256178A (es) |
| TW (1) | TW260663B (es) |
| WO (1) | WO1994007507A1 (es) |
| ZA (1) | ZA936978B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2978995A (en) * | 1994-06-30 | 1996-01-25 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Methods for treating cell proliferative disorders by modulating signal transduction |
| EP0809492A4 (en) * | 1995-02-17 | 2007-01-24 | Smithkline Beecham Corp | IL-8 RECEPTOR ANTAGONISTS |
| US5780483A (en) * | 1995-02-17 | 1998-07-14 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| US6083920A (en) * | 1995-12-21 | 2000-07-04 | Ayurcore, Inc. | Compositions for modulating intracellular inositol trisphosphate concentration |
| US6005008A (en) * | 1996-02-16 | 1999-12-21 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| US6211373B1 (en) | 1996-03-20 | 2001-04-03 | Smithkline Beecham Corporation | Phenyl urea antagonists of the IL-8 receptor |
| US6262113B1 (en) | 1996-03-20 | 2001-07-17 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| KR20000022273A (ko) | 1996-06-27 | 2000-04-25 | 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 | Il-8 수용체 길항제 |
| CZ425598A3 (cs) * | 1996-06-27 | 1999-08-11 | Smithkline Beecham Corporation | Antagonista IL-8 receptoru |
| CA2427757A1 (en) * | 2000-11-09 | 2002-05-16 | Contrimmune Biotechnology Inc. | Therapeutic uses for ip3 receptor-mediated calcium channel modulators |
| AU2012301617A1 (en) | 2011-09-02 | 2014-04-17 | Salk Institute For Biological Studies | CaMKII, IP3R, calcineurin, p38 and MK2/3 inhibitors to treat metabolic disturbances of obesity |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB781479A (en) * | 1953-08-27 | 1957-08-21 | Ciba Ltd | New polyureas and process for making them |
| US5276182A (en) * | 1990-07-09 | 1994-01-04 | The Dow Chemical Company | Process for preparing polyurea oligomers |
-
1993
- 1993-08-30 KR KR1019950701166A patent/KR950703347A/ko not_active Ceased
- 1993-08-30 HU HU9500891A patent/HUT70192A/hu unknown
- 1993-08-30 AU AU48417/93A patent/AU670962B2/en not_active Ceased
- 1993-08-30 NZ NZ256178A patent/NZ256178A/en unknown
- 1993-08-30 CA CA002145681A patent/CA2145681A1/en not_active Abandoned
- 1993-08-30 JP JP6509054A patent/JPH08502068A/ja active Pending
- 1993-08-30 EP EP93921252A patent/EP0661982A1/en not_active Ceased
- 1993-08-30 WO PCT/US1993/008168 patent/WO1994007507A1/en not_active Ceased
- 1993-09-21 ZA ZA936978A patent/ZA936978B/xx unknown
- 1993-09-22 IL IL107066A patent/IL107066A/en not_active IP Right Cessation
- 1993-09-22 TW TW082107787A patent/TW260663B/zh active
- 1993-09-27 MX MX9305933A patent/MX9305933A/es unknown
-
1995
- 1995-03-27 NO NO951163A patent/NO951163D0/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO951163L (no) | 1995-03-27 |
| ZA936978B (en) | 1994-04-18 |
| HUT70192A (en) | 1995-09-28 |
| TW260663B (es) | 1995-10-21 |
| NO951163D0 (no) | 1995-03-27 |
| NZ256178A (en) | 1997-03-24 |
| IL107066A (en) | 1998-01-04 |
| WO1994007507A1 (en) | 1994-04-14 |
| CA2145681A1 (en) | 1994-04-14 |
| HU9500891D0 (en) | 1995-05-29 |
| IL107066A0 (en) | 1993-12-28 |
| KR950703347A (ko) | 1995-09-20 |
| EP0661982A1 (en) | 1995-07-12 |
| AU670962B2 (en) | 1996-08-08 |
| AU4841793A (en) | 1994-04-26 |
| JPH08502068A (ja) | 1996-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE179892T1 (de) | Verwendung von lipid-gebundener glykoaminoglykanen zur behandlung der rheumatoider arthritis | |
| MX9305933A (es) | Metodo para antagonizar al 1,4,5-trifosfato de inositol. | |
| ATE206919T1 (de) | Verwendung des wirkstoffs flupirtin zur herstellung eines arzneimittels zur bekämpfung von muskelverspannungen | |
| CU23393A3 (es) | Compuestos inhibidores de la raf kinasa y composiciones farmacéuticas que los contienen | |
| BR0116001A (pt) | Métodos para tratar distúrbios neuropsiquiátricos com antagonistas receptores nmda | |
| ES2108120T3 (es) | Compuestos bis arilicos y heteroarilicos mono- y biciclicos que inhiben tirosina quinasa receptora de egf y/o pdgf. | |
| ES2135083T3 (es) | Trifeniletilenos para la prevencion y el tratamiento de la osteoporosis. | |
| ES2120993T3 (es) | Agentes antitromboticos. | |
| DE69022953D1 (de) | Zusammensetzungen zur Behandlung von Fettablagerungen. | |
| PT729468E (pt) | Antagonistas nao peptidicos de receptores de taquiquininas | |
| MX9204661A (es) | Compuestos intermedios derivados de eter y procedimiento para su preparacion. | |
| ES2116436T5 (es) | Carbamatos y agentes fitosanitarios que contienen estos. | |
| PT841928E (pt) | Formulacao de libertacao prolongada de d-trep-metilfenidato | |
| PA8443001A1 (es) | Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas | |
| ATE211384T1 (de) | Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera | |
| GB2223169B (en) | Inositol trisphosphate for the treatment of bone disorders | |
| ES2011427T3 (es) | Derivados de la oxima de octahidronaftaleno para la inhibicion de la sintesis del colesterol, procedimientos para su preparacion y composiciones que los contienen. | |
| IT1247796B (it) | Derivati arilvinilamidici e procedimento per la loro preparazione | |
| MX9301298A (es) | Seudopeptidos, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| BR8902892A (pt) | Processo para a preparacao de hidrazinas substituidas e composicao inseticida | |
| DE69432124D1 (de) | Verwendung eines inositoltriphosphatester, zur herstellung eines medikamentes | |
| AR059965A2 (es) | Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante | |
| SE9404568D0 (sv) | The use of inositoltrisphosphate for the preparing of medicaments | |
| MX9305914A (es) | 2-arilpirroles, procedimiento para su preparacion y agentes pesticidas quelos contienen. | |
| MX166685B (es) | Proceso para la preparacion de alcanosulfonamidas y arenosulfonamidas |